Surmodics to Webcast Fourth Quarter and Fiscal Year 2016 Earnings Conference Call on November 16
November 08 2016 - 7:05AM
Business Wire
Webcast is Live at 7:30 a.m. (CT)
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical
device and in vitro diagnostic technologies to the healthcare
industry, today announced that it will host a live webcast of its
fourth quarter and fiscal year 2016 conference call on Wednesday,
November 16, at 7:30 a.m. CT (8:30 a.m. ET). The Company will
issue an earnings news release earlier that morning.
Gary Maharaj, president and chief executive officer, and Andy
LaFrence, vice president of finance and information systems and
chief financial officer, will recap the fourth quarter and fiscal
year 2016 financial results and accomplishments as well as provide
2017 guidance. To access the webcast, go to the investor relations
portion of the Company’s website at www.surmodics.com the day of
the conference call and click on the webcast icon.
An audio replay will be available beginning at 10:30 a.m. CT on
Wednesday, November 16, until 10:30 a.m. CT on Wednesday,
November 23, and can be accessed by dialing 888-203-1112 and
entering conference call ID passcode 8067923. In addition, the
conference call audio and transcript will be archived on the
Company’s website following the call.
About Surmodics, Inc.
Surmodics is the global leader in surface modification
technologies for intravascular medical devices and a leading
provider of chemical components for in vitro diagnostic (IVD) tests
and microarrays. Following two recent acquisitions of Creagh
Medical and NorMedix, the Company is executing a key growth
strategy for its medical device business by expanding to offer
total intravascular product solutions to its medical device
customers. The combination of proprietary surface technologies,
along with enhanced device design, development and manufacturing
capabilities, enables Surmodics to significantly increase the value
it offers with highly differentiated intravascular solutions
designed and engineered to meet the most demanding requirements.
With this focus on offering total product solutions, Surmodics’
mission remains to improve the detection and treatment of disease
by using its technology to provide solutions to difficult medical
device and diagnostic challenges. Surmodics is headquartered in
Eden Prairie, Minnesota. For more information about the company,
visit www.surmodics.com. The content of Surmodics’ website is not
part of this press release or part of any filings that the company
makes with the SEC.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161108005243/en/
Surmodics, Inc.Andy LaFrence,
952-500-7000ir@surmodics.com
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Apr 2024 to May 2024
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From May 2023 to May 2024